Quest PharmaTech Inc. (TSXV:QPT)

Quest PharmaTech Income Statement

Financials in millions CAD. Fiscal year is February - January.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Selling, General & Admin	0.5	0.49	0.82	0.54	0.64	0.87
Research & Development	0.32	0.33	0.5	0.3	0.15	0.2
Operating Expenses	0.82	0.82	1.32	0.83	0.79	1.07
Operating Income	-0.82	-0.82	-1.32	-0.83	-0.79	-1.07
Interest Expense	-0.02	-0.02	-0.02	-0.02	-0.01	-0.01
Interest & Investment Income	-	-	-	-	-	0
Earnings From Equity Investments	0.01	-0.8	-0.52	-3.1	-57.75	164.17
Currency Exchange Gain (Loss)	0	0	-0	-0	-0	0
Other Non Operating Income (Expenses)	0.3	0.3	0.17	0.45	0.24	0.21
EBT Excluding Unusual Items	-0.53	-1.34	-1.68	-3.5	-58.32	163.31
Gain (Loss) on Sale of Investments	0.29	-0.46	-1.34	-61.39	-26.72	-101.56
Gain (Loss) on Sale of Assets	-	-	-	-	-	128.32
Pretax Income	-0.24	-1.8	-3.02	-64.89	-85.04	190.06
Earnings From Continuing Operations	-0.24	-1.8	-3.02	-64.89	-85.04	190.06
Net Income to Company	-0.24	-1.8	-3.02	-64.89	-85.04	190.06
Net Income	-0.24	-1.8	-3.02	-64.89	-85.04	190.06
Net Income to Common	-0.24	-1.8	-3.02	-64.89	-85.04	190.06
Shares Outstanding (Basic)	169	169	169	168	168	168
Shares Outstanding (Diluted)	169	169	169	168	168	171
Shares Change (YoY)	-	-	0.44%	0.09%	-1.57%	2.10%
EPS (Basic)	-0.00	-0.01	-0.02	-0.39	-0.51	1.13
EPS (Diluted)	-0.00	-0.01	-0.02	-0.39	-0.51	1.11
Free Cash Flow	-0.45	-0.51	-0.34	-0.55	-0.17	-2.52
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.01
EBITDA	-	-0.81	-1.31	-0.82	-0.79	-1.07
D&A For EBITDA	-	0	0	0.01	0	0
EBIT	-0.82	-0.82	-1.32	-0.83	-0.79	-1.07

Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.